KD
Kirti Dwarkadas Gaudani
About Kirti Dwarkadas Gaudani
Data last updated:
Kirti Dwarkadas Gaudani is a Director at Flax Laboratories Private Limited (since 2025) and Director at Linum Healthcare Private Limited (since 2018). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹61.63 Cr; the largest is Flax Laboratories Private Limited at ₹52.86 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Flax Laboratories Private Limited U24239MH2021PTC359917 | Director | 01 Apr 2025 | 2021 | ₹52.86 Cr (FY 2025) | Active |
 Linum Healthcare Private Limited U24117GJ2018PTC102221 | Director | 08 May 2018 | 2018 | ₹8.77 Cr (FY 2025) | Active |
Board colleagues of Kirti Dwarkadas Gaudani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaybhai Subodhbhai Maheta | 07766698 | Flax Laboratories Private Limited | Director |
| Bharatbhai Govindbhai Suthar | 07766631 | Flax Laboratories Private Limited | Director |
| Hetal Maheta Abhay | 07765857 | Flax Laboratories Private Limited | Director |
| Rajni Dwarkadas Gaudani | 07765846 | Flax Laboratories Private Limited , Linum Healthcare Private Limited | Director |
| Rekhaben Bharatbhai Suthar | 07765821 | Flax Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kirti Dwarkadas Gaudani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kirti Dwarkadas Gaudani
Kirti Dwarkadas Gaudani currently holds 2 directorships: Flax Laboratories Private Limited (Director, since 01 Apr 2025, revenue ₹52.86 Cr (FY 2025)); Linum Healthcare Private Limited (Director, since 08 May 2018, revenue ₹8.77 Cr (FY 2025)).
Kirti Dwarkadas Gaudani was first appointed on 08 May 2018 as Director at Linum Healthcare Private Limited. The most recent appointment on record is 01 Apr 2025 at Flax Laboratories Private Limited.
The 2 current companies of Kirti Dwarkadas Gaudani that report revenue have a combined latest revenue of ₹61.63 Cr: Flax Laboratories Private Limited ₹52.86 Cr (FY 2025); Linum Healthcare Private Limited ₹8.77 Cr (FY 2025).
The current boards of Kirti Dwarkadas Gaudani's companies include Abhaybhai Subodhbhai Maheta (Flax Laboratories Private Limited), Bharatbhai Govindbhai Suthar (Flax Laboratories Private Limited), Hetal Maheta Abhay (Flax Laboratories Private Limited), Rajni Dwarkadas Gaudani (Flax Laboratories Private Limited), Rekhaben Bharatbhai Suthar (Flax Laboratories Private Limited).